Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate whether a supplementation of 20 µg Vitamin D3 per day for 12 weeks can be used to normalize vitamin d-Status


Clinical Trial Description

It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to normalize insufficient vitamin d status and reduce atherosclerotic risk factors such as hypertension, inflammation and hyperlipidemia. The research question is whether Vitamin D3 reduces the level of systemic inflammation and whether Vitamin D3 has an effect on blood lipids. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01711905
Study type Interventional
Source Martin-Luther-Universität Halle-Wittenberg
Contact
Status Completed
Phase N/A
Start date November 2012
Completion date April 2013

See also
  Status Clinical Trial Phase
Completed NCT01554241 - Optimizing Vitamin D in the Elderly N/A
Completed NCT01422122 - Study of Vitamin D Supplementation on Improvement of Gums Health N/A
Terminated NCT02532062 - The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer N/A
Completed NCT01501916 - Effect of Vitamin D3 on Cardiovascular Risk Factors N/A
Completed NCT02921204 - Dietary Intake and Vitamin D Level in Adult Women N/A